WPRIM Management System> DCMS> Chinese Journal of Experimental and Clinical Virology> 2011> 25> 6

Volume: 25 Issue: 6

1. Construction and expression of a novel HBeAg binding protein 1 of hepatitis B virus in yeast. Page:489—491
2. Surveillance of healthy people's Japanese encephalitis neutralizing antibody in some areas of Henan Province Page:401—404
3. Expression, purification and identification of St.Louis encephalitis virus-like particles in eukaryotic cells Page:405—408
4. Genetic analysis of echovirus 30 isolated from acute meningitis/encephalitis syndrome cases in Linyi city of Shandong province, China Page:409—412
5. Anti-adenovirus neutralizing antibodies and Gag-specific cellular immune responses in Macaca fascicularis immunized with Ad5-HIVgag Page:413—415
6. Study on the effect of realgar nanoparticles anfi-adenovirus in vitro Page:416—419
7. Improved expression of human rotavirus VP6 antigen in the recombinant adenoviruse by codon optimization Page:420—422
8. Transcription pattern of UL131A-128 mRNA in HCMV clinical strains Page:423—426
9. The study on high-resolution HLA and human cytomegalovirus (HCMV) viremia in bone marrow transplantation recipients Page:427—430
10. Study on vector-specific and foreign gene-speciflc immune responses induced by rAd5 and rAAV2/1 vaccines Page:431—433
11. Epidemiological analysis of rabies in 2010, China Page:434—436
12. Molecular characteristics of noroviruses causing outbreaks of acute gastroenteritis in Huzhou Page:437—440
13. The associated research on the expression of RUNX3 mRNA and protein in hepatic cell carcinoma as well as the relationship with clinical pathological parameters Page:441—444
14. Analysis of the test results of HBV serum markers and HBV DNA of the neonates born to HBsAg-positive mothers Page:445—447
15. Hepatitis C viruse infection situation in the human population of six provinces in China Page:448—449
16. The chracteration analy of HAV recombinant antigen was expressed by vaccinia virus vector Page:450—452
17. The clinical efficacy and safety of adefovir dipivoxil in combination with bicyclol for the treatment of senior patients with chronic hepatitis B Page:453—456
18. Investigation and analysis of occult hepatitis B virus infection among voluntary blood donors in Lishui area Page:457—459
19. Clinical characteristics of hepatitis B virus-related acute-on-chronic liver failure patients with familial aggregation Page:460—462
20. Expression of fibroblast activation protein in HBV related hepatocellular carcinoma Page:463—465
21. Discussion on the meaning of MELD score in the opportunity of the entecavir treatment of HBeAg-negative acute-on-chronic liver failure Page:466—469
22. Genotyping and mutational analysis of occult hepatitis B virus infection in blood donors of Shaoxing Page:470—473
23. Clinical significance and detection of the expression of CD25 - CD127 - on CD4 + T cells in peripheral blood in patients with hepatitis B Page:474—476
24. Efficacy of peg interferon α-2a in combination with ribavirin in treatment of with hepatitis C cirrhosis patients Page:477—479
25. PPARγagonists against respiratory syncytial virus infection in vitro study Page:480—482
26. The level of peripheral circular DNA in patients with hand foot and mouth disease Page:483—485
27. A study of immunoassay by using quantum dots to detect Hantavirus infection Page:486—488
28. Establishment of confirmatory test for HBsAb in serum of coexistence of hepatitis B surface antigen and antibodies to HBsAg Page:492—494
29. Evaluation of the helicobacter pylori stool antigen test Page:495—496

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.